Impairment of cell-mediated immunity in mutation diabetic mice (db/db).
Mutation diabetes in the mouse occurs in the C57BL/Ks strain. All homozygous animals (db/db) develop obesity, elevated blood sugar levels and increased or normal blood insulin concentration. The defects in cellular immunity in db/db mice and their littermate controls were examined both in vivo and in vitro. Significant suppression of delayed footpad swelling and first and second set skin allograft rejection time were observed. In addition, DNA synthesis in spleen cells after nonspecific mitogen stimulation was markedly inhibited. Diabetic animals with a mean blood sugar of 512 +/- 101 mg/100 ml did not respond to exogenous insulin therapy by lowering their blood sugar levels or reversing the defect in DNA synthesis. Adding insulin to spleen cell culture in vitro had no demonstrable effect on their response to mitogens. Thus, mutation diabetic mice with their known defect in the peripheral utilization of insulin have markedly suppressed cell-mediated immune mechanisms.
D000818:Animals; D001786:Blood Glucose; D004247:DNA / Q000096:biosynthesis; D003921:Diabetes Mellitus, Experimental / Q000276:immunology*; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D009154:Mutation; D016038:Skin Transplantation; D013936:Thymidine / Q000378:metabolism; D014184:Transplantation, Homologous
D001786:Blood Glucose; D004247:DNA; D013936:Thymidine